Oncogenic mutations of ALK in neuroblastoma

Seishi Ogawa1, Junko Takita, Masashi Sanada

  • 1Cancer Genomics Project, The University of Tokyo, Tokyo, Japan. sogawa-tky@umin.ac.jp

Cancer Science
|January 6, 2011
PubMed

Insights

Anaplastic lymphoma kinase (ALK) mutations drive advanced neuroblastoma, a common childhood cancer. Targeting these ALK mutations with inhibitors offers a promising therapeutic strategy for improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a prevalent pediatric solid cancer with a poor prognosis for advanced stages.
  • Current chemo/radiotherapies have limited efficacy in improving outcomes for advanced neuroblastoma.
  • Identifying key pathogenic molecules is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of Anaplastic Lymphoma Kinase (ALK) in neuroblastoma pathogenesis.
  • To evaluate the therapeutic potential of targeting ALK in neuroblastoma.

Main Methods:

  • Analysis of ALK mutations in sporadic and hereditary neuroblastoma cases.
  • Assessment of ALK mutant activity and oncogenic potential.
  • Inhibition of ALK in neuroblastoma cell lines with mutated or amplified ALK alleles.

Main Results:

  • Anaplastic Lymphoma Kinase (ALK) is frequently mutated in sporadic and hereditary neuroblastoma.
  • ALK mutations lead to constitutive kinase activity and oncogenic potential.
  • Inhibiting ALK compromises downstream signaling and reduces cell growth in neuroblastoma cell lines.

Conclusions:

  • Mutated or amplified ALK is a key driver in a significant subset of neuroblastoma.
  • Small molecule ALK inhibitors demonstrate therapeutic potential for neuroblastoma patients with ALK alterations.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...